| Product Code: ETC9968261 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Insource Intraoperative Neuromonitoring Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Insource Intraoperative Neuromonitoring Market - Industry Life Cycle |
3.4 United States (US) Insource Intraoperative Neuromonitoring Market - Porter's Five Forces |
3.5 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Insource Intraoperative Neuromonitoring Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for intraoperative neuromonitoring services in the United States due to rising cases of neurological disorders and surgeries involving the nervous system. |
4.2.2 Technological advancements leading to the development of more sophisticated neuromonitoring equipment and techniques, improving accuracy and outcomes. |
4.2.3 Growing awareness among healthcare providers about the benefits of intraoperative neuromonitoring in reducing risks during surgeries and enhancing patient safety. |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for intraoperative neuromonitoring services in the United States, which may hinder market growth. |
4.3.2 Shortage of skilled professionals trained in intraoperative neuromonitoring, leading to challenges in meeting the increasing demand for these services. |
4.3.3 High initial setup costs associated with implementing intraoperative neuromonitoring programs in healthcare facilities, potentially deterring adoption. |
5 United States (US) Insource Intraoperative Neuromonitoring Market Trends |
6 United States (US) Insource Intraoperative Neuromonitoring Market, By Types |
6.1 United States (US) Insource Intraoperative Neuromonitoring Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Insource IONM, 2021- 2031F |
6.1.4 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Outsource IONM, 2021- 2031F |
6.2 United States (US) Insource Intraoperative Neuromonitoring Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Neurosurgery, 2021- 2031F |
6.2.3 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By SpinalSurgery, 2021- 2031F |
6.2.4 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Cardiovascular Surgery, 2021- 2031F |
6.2.5 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By ENT Surgery, 2021- 2031F |
6.2.6 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Orthopedic Surgery, 2021- 2031F |
6.2.7 United States (US) Insource Intraoperative Neuromonitoring Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Insource Intraoperative Neuromonitoring Market Import-Export Trade Statistics |
7.1 United States (US) Insource Intraoperative Neuromonitoring Market Export to Major Countries |
7.2 United States (US) Insource Intraoperative Neuromonitoring Market Imports from Major Countries |
8 United States (US) Insource Intraoperative Neuromonitoring Market Key Performance Indicators |
8.1 Average response time for neuromonitoring alerts during surgeries, indicating the efficiency of monitoring processes. |
8.2 Rate of successful neuromonitoring interventions during surgeries, reflecting the effectiveness of the technology and techniques employed. |
8.3 Number of healthcare facilities adopting in-house intraoperative neuromonitoring programs, showing market penetration and growth potential. |
9 United States (US) Insource Intraoperative Neuromonitoring Market - Opportunity Assessment |
9.1 United States (US) Insource Intraoperative Neuromonitoring Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Insource Intraoperative Neuromonitoring Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Insource Intraoperative Neuromonitoring Market - Competitive Landscape |
10.1 United States (US) Insource Intraoperative Neuromonitoring Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Insource Intraoperative Neuromonitoring Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |